查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1835559

微生物組定序服務市場（按樣本類型、技術、應用和最終用戶）—全球預測 2025-2032

Microbiome Sequencing Services Market by Sample Type, Technology, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年微生物組定序服務市場將成長至 63.8 億美元，複合年成長率為 15.25%。

主要市場統計數據
基準年2024年 20.4億美元
預計2025年 23.6億美元
預測年份：2032年 63.8億美元
複合年成長率（%） 15.25%

一個重要的背景框架，揭示了技術成熟度、工作流程標準化和資料整合如何重塑服務選擇和相關人員的期望。

由於技術創新的加速、應用的多樣化以及跨部門合作的加強，微生物組定序服務正在快速發展。這種應用隨後為解讀洞見提供了必要的背景。定序模式已經成熟，超越了概念驗證，能夠提供可重複的臨床相關數據。樣本採集通訊協定正朝著標準化工作流程發展，以減少分析前的差異性。總而言之，這些發展正在重新定義實驗室、診斷公司、製藥研究人員和環境從業人員採購定序服務的方式，並將結果整合到決策流程中。

重要的是，本概述強調了科學研究能力與商業性部署之間的相互作用。擴增子、總體轉錄組和鳥槍法宏基因組學方法的進步正在擴大可解決問題的範圍，從分類分析到功能推斷和轉錄活性狀態。同時，需求模式也在改變。臨床和製藥行業的相關人員需要經過驗證且合規的工作流程和快速的周轉，而農業和環境用戶則優先考慮可擴展性、在土壤和水等可變基質中的穩健性以及成本效益。因此，相關人員應從預期應用和下游分析的檢驗來解讀技術選擇，而不是孤立地看待技術升級。有了這個框架，讀者就可以評估針對以下章節中討論的細分、區域動態以及貿易和政策壓力的戰術性應對措施。

定序模式的快速發展、嚴格的工作流程標準化以及以結果為導向的夥伴關係關係如何重新定義服務模式和競爭差異化

微生物組定序領域正在經歷一場變革性的轉變，涵蓋技術創新、價值鏈重建以及多體學觀點的整合。標靶擴增子方法正在最佳化，以實現經濟高效的分類學研究，而鳥槍法宏基因組學和宏轉錄組學則被用於捕獲功能潛力和活躍的基因表現。這種二分法將促成差異化服務，在速度和規模與解析度和可解釋性之間取得平衡，迫使服務供應商清晰地描述每種模式的效能範圍。

其次，標準化樣本處理和品管框架的興起正在減少研究間差異，並實現更可靠的隊列間比較。這種標準化，加上生物資訊學可重複性和容器化工作流程的改進，正在降低臨床和工業客戶外包的門檻。因此，委外研發機構和專業定序中心正在擴展附加價值服務，例如檢驗的流程、解釋性報告和監管支援。第三，微生物組數據與臨床、農業和環境元資料的整合正在推動整合分析平台的發展，這些平台不僅提供原始數據，還提供切實可行的見解。因此，成功的提供者正在從單純的服務交付轉向以結果為導向的夥伴關係關係，強調問題定義、客製化實驗設計和以決策為中心的報告。最後，地緣政治和供應鏈動態正在推動對區域產能和試劑冗餘的投資，從而影響整個生態系統的策略夥伴關係和採購決策。

評估關稅主導的供應鏈重組、在地化採購和庫存策略如何改變定序服務的採購、檢驗和夥伴關係方法

2025年美國宣布的關稅措施的累積影響正在波及微生物組定序服務中使用的試劑、儀器和輔助耗材的整個供應鏈。關稅帶來的成本壓力正促使供應商和最終用戶重新考慮籌資策略，許多供應商優先考慮供應商多元化和本地製造合作夥伴關係，以減輕影響。同時，經銷商和服務實驗室正在修改其定價模式，以反映進口設備不斷上升的到岸成本，同時平衡限制其完全轉嫁給客戶的競爭壓力。這種緊張局勢促使合約談判傾向於長期供應協議、數量承諾以及供應商和客戶之間的庫存風險共用合作。

企業因應措施包括儲備關鍵試劑、尋找替代供應商以及加速國產耗材的檢驗，以確保服務連續性。對平台製造商而言，關稅主導的利潤率壓縮正促使他們探索區域組裝和在地化，以在關鍵市場保持競爭力。同時，研究和臨床客戶正在調整計劃時間表和採購週期，以適應前置作業時間波動，一些客戶正在轉向更高通量的批量策略，以最佳化試劑利用率。監管和合規性影響也正在顯現，診斷級定序實驗室現在必須確保在因關稅相關短缺而替代試劑和組件時，經過檢驗的工作流程不會受到影響。整體而言，關稅環境可能會提高供應鏈彈性和協作採購模式的策略重要性，加速對冗餘和近岸外包的投資，並影響供應商的上市選擇和夥伴關係的發展。

詳細的細分分析揭示了樣本類型、定序技術、應用領域和最終用戶需求如何決定工作流程設計和價值提案

細分洞察揭示了樣本類型、定序技術、應用和最終用戶的不同需求動態和服務要求。按樣本類型分類，研究和服務通常涉及糞便檢體、口腔拭子和唾液、皮膚拭子、各種土壤基質和水樣，每種樣本都存在獨特的分析前限制和提取挑戰，從而影響通訊協定選擇和預期數據品質。例如，糞便和土壤樣本通常需要嚴格的核酸萃取和抑制劑去除步驟，而口腔和皮膚基質則強調低生質能處理和污染控制。因此，能夠針對特定樣本類別展示有效提取和品質控制工作流程的定序供應商將獲得臨床和環境客戶的高度信任。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 整合人工智慧和鳥槍法宏基因組學對腸道健康進行預測分析
  • 利用高解析度菌株水平定序資料開發有針對性的益生菌
  • 採用即時奈米孔定序平台在臨床環境中進行現場微生物組分析
  • 透過整合來自宏轉錄組學和代謝體學的多組體學數據，獲得全面的微生物組洞察
  • 標準化生物資訊學流程的出現，減少了微生物組序列分析的變異性
  • 使用綜合鳥槍法宏基因組學檢測進行糞便微生物移植篩檢的需求日益增加
  • 基於微生物組的藥物發現定序提供者與製藥公司之間的策略夥伴關係
  • 不斷發展的法規結構以解決臨床微生物組定序研究中的數據隱私和倫理問題

第6章 2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 微生物組定序服務市場（依樣本類型）

  • 屎
  • 口服
  • 皮膚
  • 土壤
  • 水

9. 微生物組定序服務市場（依技術）

  • 擴增子定序
    • 16S rRNA測序
    • 內部轉錄間隔序列
  • 總體轉錄組定序
  • 鳥槍法宏基因組定序

第 10 章微生物組定序服務市場（依應用）

  • 農業和畜牧業
    • 作物品質監測
    • 牲畜健康監測
  • 臨床診斷
    • 消化系統疾病的診斷
    • 感染疾病診斷
  • 消費者基因體學
    • 家庭檢測
    • 基於臨床的檢測
  • 環境監測
    • 土壤健康監測
    • 水質監測
  • 藥物研發
    • 藥物研發
    • 微生物組治療發展

第 11 章微生物組定序服務市場（依最終用戶）

  • 學術研究機構
  • 臨床診斷實驗室
  • 消費者基因組學公司
  • 合約研究組織
  • 製藥和生物製藥公司

12. 微生物組定序服務市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 13 章微生物組定序服務市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 微生物組定序服務市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • QIAGEN NV
    • F. Hoffmann-La Roche AG
    • Danaher Corporation
    • Eurofins Scientific SE
    • BGI Genomics Co., Ltd.
    • Novogene Co., Ltd.
    • Adaptive BIoTechnologies Corp.
    • WuXi AppTec Co., Ltd.
Product Code: MRR-036C5CF3A80E

The Microbiome Sequencing Services Market is projected to grow by USD 6.38 billion at a CAGR of 15.25% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.04 billion
Estimated Year [2025] USD 2.36 billion
Forecast Year [2032] USD 6.38 billion
CAGR (%) 15.25%

Essential contextual framing that clarifies how technological maturity, workflow standardization, and data integration are reshaping service selection and stakeholder expectations

The microbiome sequencing services landscape is evolving rapidly, driven by accelerated technological innovation, diversified applications, and intensifying cross-sector collaboration. This introduction synthesizes the essential context needed to interpret subsequent insights: sequencing modalities have matured beyond proof-of-concept to deliver reproducible, clinically relevant data; sample acquisition protocols are converging on standardized workflows that reduce pre-analytical variability; and computational pipelines are being professionalized to handle high-throughput data while meeting regulatory and privacy expectations. Taken together, these developments are redefining how laboratories, diagnostic companies, pharmaceutical researchers, and environmental practitioners procure sequencing services and integrate outputs into decision-making processes.

Importantly, this overview emphasizes the interplay between scientific capability and commercial deployment. Advances in amplicon, metatranscriptomic, and shotgun metagenomic approaches have widened the range of resolvable questions, from taxonomic profiling to functional inference and active transcriptional states. At the same time, demand patterns are shifting: clinical and pharmaceutical stakeholders require validated, compliant workflows with rapid turnaround, whereas agricultural and environmental users prioritize scalability, robustness in variable matrices such as soil and water, and cost-efficiency. Therefore, stakeholders should interpret technology choices through the lens of intended application and downstream analytics rather than as isolated technical upgrades. This framing prepares readers to assess segmentation, regional dynamics, and tactical responses to trade and policy pressures discussed in subsequent sections.

How rapidly advancing sequencing modalities, rigorous workflow standardization, and outcome-oriented partnerships are redefining service models and competitive differentiation

The microbiome sequencing sector is undergoing transformative shifts that span technological innovation, value chain reconfiguration, and integration of multi-omic perspectives. First, sequencing technology trajectories have diverged: targeted amplicon approaches are being optimized for cost-effective taxonomic surveys, while shotgun metagenomics and metatranscriptomics are being deployed to capture functional potential and active gene expression. This bifurcation enables differentiated service offerings where speed and scale are balanced against resolution and interpretability, and it compels service providers to articulate clearly the performance envelope of each modality.

Second, the rise of standardized sample handling and quality-control frameworks is diminishing variability across studies and enabling more reliable cross-cohort comparisons. This standardization, paired with improvements in bioinformatics reproducibility and containerized workflows, lowers barriers to outsourcing for clinical and industrial clients. As a result, contract research organizations and specialized sequencing centers are expanding value-added services such as validated pipelines, interpretive reporting, and regulatory support. Third, the convergence of microbiome data with clinical, agronomic, and environmental metadata is catalyzing the development of integrated analytics platforms that provide actionable insights rather than raw data alone. Consequently, successful providers are shifting from pure service delivery to outcome-oriented partnerships that emphasize problem definition, tailored experimental design, and decision-focused reporting. Finally, geopolitical and supply-chain dynamics are prompting investments in regional capacity and reagent redundancy, which in turn influence strategic partnerships and sourcing decisions across the ecosystem.

Assessing how tariff-driven supply chain realignment, localized sourcing, and inventory strategies are altering procurement, validation, and partnership approaches across sequencing services

The cumulative impact of United States tariff actions announced in 2025 has reverberated across supply chains for reagents, instrumentation, and ancillary consumables used in microbiome sequencing services. Tariff-induced cost pressures have prompted providers and end users to reexamine procurement strategies, with many prioritizing supplier diversification and local manufacturing partnerships to mitigate exposure. In parallel, distributors and service labs have recalibrated pricing models to reflect increased landed costs for imported equipment while balancing competitive pressures that limit full pass-through to customers. This tension has fuelled contract negotiations that favor longer-term supply agreements, volume commitments, and collaborative arrangements that share inventory risk between vendors and clients.

Operational responses have included stockpiling critical reagents, qualifying alternative suppliers, and accelerating validation of domestically produced consumables to ensure continuity of service. For platform manufacturers, tariff-driven margin compression has incentivized exploration of regional assembly and localized component sourcing to maintain competitiveness in key markets. At the same time, research and clinical customers have adjusted project timelines and procurement cycles to accommodate lead-time variability, and some have shifted toward higher-throughput batching strategies to optimize reagent utilization. Regulatory and compliance implications have surfaced as well; laboratories engaged in diagnostic-grade sequencing have had to ensure that validated workflows remain intact when substituting reagents or components due to tariff-related shortages. Overall, the tariff environment has heightened the strategic importance of supply chain resilience and collaborative procurement models, accelerating investments in redundancy and nearshoring that will influence suppliers' go-to-market choices and partnership architectures.

In-depth segmentation analysis revealing how sample type, sequencing technology, application domain, and end-user requirements dictate workflow design and value proposition

Segmentation insights reveal differentiated demand dynamics and service requirements across sample types, sequencing technologies, applications, and end users. Based on sample type, studies and services routinely address fecal specimens, oral swabs and saliva, skin swabs, diverse soil matrices, and water samples, each presenting unique pre-analytical constraints and extraction challenges that influence protocol selection and data quality expectations. For example, fecal and soil samples typically require robust nucleic acid extraction and inhibitor removal steps, while oral and skin matrices emphasize low-biomass handling and contamination control. Consequently, sequencing providers that can demonstrate validated extraction and QC workflows for specific sample classes often capture higher confidence from clients in clinical and environmental domains.

Based on technology, service portfolios are organized around amplicon sequencing, metatranscriptomic sequencing, and shotgun metagenomic sequencing. Amplicon sequencing is commonly subdivided into 16S rRNA sequencing for bacterial community profiling and Internal Transcribed Spacer (ITS) sequencing for fungal community characterization, offering cost-effective taxonomic resolution for many surveillance and exploratory studies. Shotgun metagenomics delivers broader taxonomic and functional resolution and is preferred when species-level discrimination and genomic context are required, while metatranscriptomic approaches reveal active gene expression patterns that inform mechanistic hypotheses and therapeutic target identification. The selection among these technologies depends on trade-offs between cost, depth, and interpretive complexity, and providers are increasingly packaging hybrid workflows to meet hybrid client needs.

Based on application, the spectrum includes Agricultural & Animal Husbandry, Clinical Diagnostics, Consumer Genomics, Environmental Monitoring, and Pharmaceutical R&D. Agricultural and animal husbandry use cases break down into crop quality monitoring and livestock health monitoring, where actionable outputs feed agronomic decisions and herd health interventions. Clinical diagnostics comprises gastrointestinal disorder diagnosis and infectious disease diagnostics, demanding validated, reproducible pipelines and regulatory alignment. Consumer genomics splits into at-home testing and clinic-based testing, where user experience, data privacy, and interpretive clarity are central. Environmental monitoring is oriented toward soil health monitoring and water quality monitoring, requiring rugged protocols that contend with diverse matrices. Pharmaceutical R&D spans drug discovery and microbiome therapeutics development, necessitating high-resolution functional insights, longitudinal sampling, and integrated omics.

Based on end user, services are tailored for academic and research institutes, clinical diagnostic laboratories, consumer genomics companies, contract research organizations, and pharmaceutical and biopharmaceutical companies. Each end-user class imposes distinct requirements for turnaround time, validation, data governance, and reporting granularity. Academic clients often prioritize methodological flexibility and raw data access, clinical labs require compliance and interpretive certainty, consumer genomics firms emphasize scale and user-friendly reports, CROs focus on programmatic integration and documentation for regulatory filings, and pharmaceutical companies demand rigorous cross-cohort comparability and integration with clinical endpoints. Recognizing these differentiated needs enables service providers to design modular offerings that map technological choices and QA practices to client-specific success criteria.

How distinct regional investment priorities, regulatory frameworks, and capacity distributions influence sequencing service design and global delivery strategies

Regional dynamics continue to shape investment patterns, capability distribution, and regulatory complexity in microbiome sequencing services. In the Americas, strong private-sector investment, a mature clinical diagnostics ecosystem, and dense pharmaceutical and academic networks support sophisticated service offerings that combine high-throughput sequencing with advanced analytics and clinical-grade reporting. In addition, North American clients frequently drive demand for regulatory-compliant pipelines and rapid turnaround, which fosters partnerships between sequencing centers and clinical laboratories to meet stringent validation standards.

Across Europe, Middle East & Africa, the landscape is heterogeneous: Western European markets emphasize rigorous data protection, well-defined clinical pathways, and collaborative public-private research consortia, while emerging markets within the region demonstrate varied capacity and growing interest in affordable, scalable surveillance solutions for environmental and agricultural applications. Regulatory harmonization efforts and cross-border research initiatives are important trends that influence both sample movement and service deployment strategies across this region.

In the Asia-Pacific region, rapid capacity expansion, significant public research investment, and a growing base of biotech companies are accelerating adoption. Providers in this region are building integrated service models that prioritize cost efficiency and scalability while addressing local language, regulatory, and logistics requirements. Collectively, these regional patterns suggest that providers seeking global reach should balance centralized high-value capabilities with strategically located regional nodes to optimize cost, compliance, and responsiveness to local end-user needs.

Profiles of differentiated company strategies emphasizing integration, validated analytics, and collaborative ecosystems that accelerate adoption and sustain competitive advantage

Key company insights focus on capabilities, strategic positioning, and collaborative models that differentiate leading service providers and technology vendors. Market leaders tend to combine robust laboratory execution with end-to-end bioinformatics, offering validated pipelines, transparent QA metrics, and reproducible reporting formats that satisfy clinical, research, and commercial clients alike. Competitive advantage is often derived from proprietary sample preparation chemistries, validated data interpretation modules that translate complex outputs into decision-ready reports, and strong customer success functions that support study design and regulatory documentation.

Many successful organizations have pursued vertical integration to control critical parts of the value chain, including reagent development, library preparation kits, and data-hosting platforms, thereby reducing reliance on third-party suppliers and improving margin visibility. Others have adopted a modular partnership strategy, creating ecosystems that link specialized sample-prep labs, sequencing centers, and interpretive analytics firms to offer flexible, scalable solutions. Strategic collaborations with pharmaceutical companies and agricultural firms are common, driven by the need to co-develop validated assays, run large-scale longitudinal studies, and translate multi-omic findings into product development hypotheses. Finally, an emerging cohort of companies is differentiating through standards leadership-investing in interlaboratory reproducibility studies, open benchmarking datasets, and participation in regulatory working groups-to build trust and lower barriers to adoption among risk-averse end users.

Actionable strategic and operational imperatives for providers to strengthen resilience, deepen client value, and accelerate validated adoption across applications

Industry leaders should adopt a portfolio of strategic actions to capture value and mitigate risk as the microbiome sequencing landscape matures. First, prioritize investment in validated, application-specific workflows that are demonstrably reproducible across sample types and that incorporate clear QA/QC gates; this reduces client onboarding friction and protects service credibility in regulated contexts. Second, develop supplier diversification and regional sourcing strategies to buffer against tariff-driven supply shocks and logistical disruptions, complemented by formal contingency plans and multi-supplier qualification processes. Third, invest in interpretive analytics and outcome-focused reporting that translate sequencing outputs into actionable recommendations for clinical decisions, agronomic management, or therapeutic development, thereby increasing the utility and perceived value of services.

Additionally, cultivate deep partnerships with end users to co-develop assays and longitudinal study frameworks that align platform capabilities with specific program objectives. This collaborative model shortens validation cycles and generates reference datasets that solidify commercial differentiation. From an operational perspective, implement modular pricing and service tiers that align with client sophistication-from raw data delivery for academic clients to turnkey, validated reports for clinical customers-so providers can capture cross-segment demand without compromising specialization. Finally, engage proactively with regulators, standards bodies, and interlaboratory consortia to influence emerging guidelines, demonstrate compliance, and build trust-actions that will lower barriers for diagnostic and therapeutic applications over time.

Methodical approach combining literature synthesis, expert interviews, technical benchmarking, and supply-chain diagnostics to produce robust actionable insights

The research methodology underpinning this analysis combined multi-source evidence synthesis, stakeholder interviews, technical assessment, and supply-chain diagnostics to ensure robust, actionable findings. Desk research synthesized peer-reviewed literature, technical white papers, regulatory guidance documents, and technology roadmaps to construct a baseline understanding of sequencing modalities, sample-specific constraints, and analytical approaches. This secondary work was complemented by targeted primary interviews with laboratory directors, bioinformatics leaders, procurement specialists, and application scientists to surface operational realities, adoption barriers, and validation priorities that are not always visible in published literature.

Technical assessments included comparative review of lab workflows and bioinformatics pipelines to evaluate reproducibility, contamination control, and interpretive clarity across amplicon, shotgun metagenomic, and metatranscriptomic approaches. Supply-chain diagnostics evaluated reagent and instrument sourcing pathways, inventory strategies, and tariff exposure to identify resilience gaps and near-term operational risks. Findings were triangulated across sources and subjected to sensitivity checks to ensure internal consistency. Where appropriate, limitations and assumptions are clearly documented to help readers interpret the implications for different end-user contexts and to guide further deep-dive analysis tailored to specific operational needs.

Consolidated synthesis highlighting how technical plurality, validation rigor, and supply-chain resilience collectively determine the pace of practical adoption and commercialization

In conclusion, the microbiome sequencing services landscape is transitioning from a fragmented research-oriented market toward a more structured, application-driven ecosystem. Technological plurality-spanning amplicon, shotgun metagenomic, and metatranscriptomic approaches-creates opportunities for differentiated service models that address distinct resolution, cost, and interpretive requirements. Concurrently, the increasing emphasis on workflow standardization, validated analytics, and regulatory alignment is reshaping buyer expectations and elevating the importance of demonstrated reproducibility. Supply-chain pressures, including tariff-related disruptions, have highlighted the strategic value of supplier diversification and regional capacity, prompting both nearshoring and collaborative procurement strategies.

For stakeholders, success depends on aligning technical capabilities with specific application needs, investing in outcome-oriented analytics, and engaging in partnerships that accelerate validation and adoption. By integrating these priorities-resilient operations, targeted productization, and proactive regulatory engagement-providers and end users can convert scientific potential into practical, decision-ready insights that deliver value across clinical, agricultural, environmental, and pharmaceutical domains.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence with shotgun metagenomics for predictive gut health analytics
  • 5.2. Development of targeted probiotics informed by high-resolution microbial strain-level sequencing data
  • 5.3. Adoption of real-time nanopore sequencing platforms for onsite microbiome profiling in clinical settings
  • 5.4. Integration of multiomics data from metatranscriptomics and metabolomics for comprehensive microbiome insights
  • 5.5. Emergence of standardized bioinformatics pipelines to reduce variability in microbiome sequencing analysis
  • 5.6. Growing demand for fecal microbiota transplantation screening using comprehensive shotgun metagenomic assays
  • 5.7. Strategic partnerships between sequencing providers and pharmaceutical companies for microbiome-based drug discovery
  • 5.8. Regulatory frameworks evolving to address data privacy and ethical concerns in clinical microbiome sequencing studies

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Microbiome Sequencing Services Market, by Sample Type

  • 8.1. Fecal
  • 8.2. Oral
  • 8.3. Skin
  • 8.4. Soil
  • 8.5. Water

9. Microbiome Sequencing Services Market, by Technology

  • 9.1. Amplicon Sequencing
    • 9.1.1. 16S Rrna Sequencing
    • 9.1.2. Internal Transcribed Spacer Sequencing
  • 9.2. Metatranscriptomic Sequencing
  • 9.3. Shotgun Metagenomic Sequencing

10. Microbiome Sequencing Services Market, by Application

  • 10.1. Agricultural & Animal Husbandry
    • 10.1.1. Crop Quality Monitoring
    • 10.1.2. Livestock Health Monitoring
  • 10.2. Clinical Diagnostics
    • 10.2.1. Gastrointestinal Disorder Diagnosis
    • 10.2.2. Infectious Disease Diagnostics
  • 10.3. Consumer Genomics
    • 10.3.1. At-Home Testing
    • 10.3.2. Clinic-Based Testing
  • 10.4. Environmental Monitoring
    • 10.4.1. Soil Health Monitoring
    • 10.4.2. Water Quality Monitoring
  • 10.5. Pharmaceutical R&D
    • 10.5.1. Drug Discovery
    • 10.5.2. Microbiome Therapeutics Development

11. Microbiome Sequencing Services Market, by End User

  • 11.1. Academic & Research Institutes
  • 11.2. Clinical Diagnostic Laboratories
  • 11.3. Consumer Genomics Companies
  • 11.4. Contract Research Organizations
  • 11.5. Pharmaceutical & Biopharmaceutical Companies

12. Microbiome Sequencing Services Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Microbiome Sequencing Services Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Microbiome Sequencing Services Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Illumina, Inc.
    • 15.3.2. Thermo Fisher Scientific Inc.
    • 15.3.3. QIAGEN N.V.
    • 15.3.4. F. Hoffmann-La Roche AG
    • 15.3.5. Danaher Corporation
    • 15.3.6. Eurofins Scientific SE
    • 15.3.7. BGI Genomics Co., Ltd.
    • 15.3.8. Novogene Co., Ltd.
    • 15.3.9. Adaptive Biotechnologies Corp.
    • 15.3.10. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. MICROBIOME SEQUENCING SERVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. MICROBIOME SEQUENCING SERVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MICROBIOME SEQUENCING SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY FECAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY FECAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY FECAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY FECAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY FECAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY FECAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ORAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ORAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ORAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ORAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SKIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SKIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SKIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SKIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SKIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SKIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY 16S RRNA SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INTERNAL TRANSCRIBED SPACER SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INTERNAL TRANSCRIBED SPACER SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INTERNAL TRANSCRIBED SPACER SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INTERNAL TRANSCRIBED SPACER SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INTERNAL TRANSCRIBED SPACER SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INTERNAL TRANSCRIBED SPACER SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY METATRANSCRIPTOMIC SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CROP QUALITY MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CROP QUALITY MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CROP QUALITY MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CROP QUALITY MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CROP QUALITY MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CROP QUALITY MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY LIVESTOCK HEALTH MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY LIVESTOCK HEALTH MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY LIVESTOCK HEALTH MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY LIVESTOCK HEALTH MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY LIVESTOCK HEALTH MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY LIVESTOCK HEALTH MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GASTROINTESTINAL DISORDER DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GASTROINTESTINAL DISORDER DIAGNOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GASTROINTESTINAL DISORDER DIAGNOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GASTROINTESTINAL DISORDER DIAGNOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GASTROINTESTINAL DISORDER DIAGNOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GASTROINTESTINAL DISORDER DIAGNOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AT-HOME TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AT-HOME TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AT-HOME TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AT-HOME TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AT-HOME TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AT-HOME TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINIC-BASED TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINIC-BASED TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINIC-BASED TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINIC-BASED TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINIC-BASED TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINIC-BASED TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL HEALTH MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL HEALTH MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL HEALTH MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL HEALTH MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL HEALTH MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SOIL HEALTH MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER QUALITY MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER QUALITY MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER QUALITY MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER QUALITY MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER QUALITY MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY WATER QUALITY MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY MICROBIOME THERAPEUTICS DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY MICROBIOME THERAPEUTICS DEVELOPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY MICROBIOME THERAPEUTICS DEVELOPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY MICROBIOME THERAPEUTICS DEVELOPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY MICROBIOME THERAPEUTICS DEVELOPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY MICROBIOME THERAPEUTICS DEVELOPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AMPLICON SEQUENCING, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY AGRICULTURAL & ANIMAL HUSBANDRY, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CONSUMER GENOMICS, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL R&D, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE